English

ALLENA PHARMACEUTICALS, INC.

EDGAR

ALNA Quarterly report (10-Q) · filed 2022-08-15

55 filing records in this dataset, filed from 2017-10-06 to 2022-08-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 6.6 million USD 2022-06-30 Source
Exact value

6600000 USD
Long-term debt including current maturities: 12.1 million USD 2021-06-30 Source
Exact value

12061000 USD
Shares outstanding: 108 million shares 2022-06-30 Source
Exact value

107725169 shares

Reported share-count change

83.26% · 48.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

58782984 shares · 2021-06-30· Source
107725169 shares · 2022-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-43.3 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Net income: -12692000 USD · 2021-07-01 – 2021-09-30 Source
Net income: -10363000 USD · 2021-10-01 – 2021-12-31 Source
Net income: -11813000 USD · 2022-01-01 – 2022-03-31 Source
Net income: -8435000 USD · 2022-04-01 – 2022-06-30 Source

Operating cash flow

-48.9 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -32875000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -21398000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -45678000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -32875000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -20037000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -24594000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -20037000 USD · 2022-01-01 – 2022-03-31 Source

Capital expenditure

667 thousand USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Capital expenditure: 422000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 457000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 422000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 642000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 457000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 667000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 642000 USD · 2021-01-01 – 2021-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-08-15.

Financial data available through: 2021-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 2021-12-31
Net income: 7 of 11 periods available· newest 2021-12-31
Operating cash flow: 7 of 11 periods available· newest 2021-12-31
Capital expenditure: 6 of 11 periods available· newest 2021-12-31
Total assets: 6 of 11 periods available· newest 2021-12-31
Total liabilities: 6 of 11 periods available· newest 2021-12-31
Current assets: 6 of 11 periods available· newest 2021-12-31
Current liabilities: 6 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2020-12-31
Shares outstanding: 6 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 15.82 million

Prior period

−USD 32.85 million

2020-01-01 – 2020-12-31
Current period

−USD 48.66 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-48663000 − -32845000 = -15818000 USD

-32845000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-48663000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Year-over-year change in Net income: -15818000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -48663000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#3457769 Filing: 000095017022005192 Input fundies:NetIncome: -32845000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#3514974 Filing: 000095017022005192
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 17.52 million

Prior period

−USD 28.16 million

2020-01-01 – 2020-12-31
Current period

−USD 45.68 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-45678000 − -28159000 = -17519000 USD

-28159000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-45678000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Year-over-year change in Operating cash flow: -17519000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -45678000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2376636 Filing: 000095017022005192 Input fundies:OperatingCashFlow: -28159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2378621 Filing: 000095017022005192
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+2.6%

Prior period

USD 650,000

2020-01-01 – 2020-12-31
Current period

USD 667,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

667000 − 650000 = 17000 USD

650000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
667000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Year-over-year change in Capital expenditure: 17000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 667000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2386824 Filing: 000095017022005192 Input fundies:CapitalExpenditure: 650000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2388797 Filing: 000095017022005192
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 14.25 million Exact value Exact value: -14247000 USD 2015-01-01 – 2015-12-31: -14247000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2015-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -14247000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14247000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459018006811/alna-20171231.xml#162624 Filing: 000156459018006811 The citation records this snapshot. The page link may show a newer release later.	−USD 13.18 million Exact value Exact value: -13175000 USD 2015-01-01 – 2015-12-31: -13175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2015-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -13175000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13175000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459018006811/alna-20171231.xml#196046 Filing: 000156459018006811 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 24.51 million Exact value Exact value: -24507000 USD 2016-01-01 – 2016-12-31: -24507000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2016-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -24507000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24507000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459019006630/alna-20181231.xml#110791 Filing: 000156459019006630 The citation records this snapshot. The page link may show a newer release later.	−USD 23.39 million Exact value Exact value: -23394000 USD 2016-01-01 – 2016-12-31: -23394000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2016-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -23394000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23394000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459019006630/alna-20181231.xml#142799 Filing: 000156459019006630 The citation records this snapshot. The page link may show a newer release later.	USD 102,000 Exact value Exact value: 102000 USD 2016-01-01 – 2016-12-31: 102000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2016-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 102000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 102000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459019006630/alna-20181231.xml#143428 Filing: 000156459019006630 The citation records this snapshot. The page link may show a newer release later.	−USD 23.5 million Calculation and evidence -23394000 − 102000 USD Exact free cash flow: -23496000 USD 2016-01-01 – 2016-12-31: -23394000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 102000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2016-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -23496000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23394000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459019006630/alna-20181231.xml#142799 Filing: 000156459019006630 Input fundies:CapitalExpenditure: 102000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459019006630/alna-20181231.xml#143428 Filing: 000156459019006630 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 21.65 million Exact value Exact value: -21650000 USD 2017-01-01 – 2017-12-31: -21650000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2017-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -21650000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21650000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459020010991/alna-20191231.xml#117203 Filing: 000156459020010991 The citation records this snapshot. The page link may show a newer release later.	−USD 21.07 million Exact value Exact value: -21065000 USD 2017-01-01 – 2017-12-31: -21065000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2017-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -21065000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21065000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459020010991/alna-20191231.xml#146503 Filing: 000156459020010991 The citation records this snapshot. The page link may show a newer release later.	USD 57,000 Exact value Exact value: 57000 USD 2017-01-01 – 2017-12-31: 57000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2017-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 57000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459020010991/alna-20191231.xml#147133 Filing: 000156459020010991 The citation records this snapshot. The page link may show a newer release later.	−USD 21.12 million Calculation and evidence -21065000 − 57000 USD Exact free cash flow: -21122000 USD 2017-01-01 – 2017-12-31: -21065000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 57000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2017-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -21122000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21065000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459020010991/alna-20191231.xml#146503 Filing: 000156459020010991 Input fundies:CapitalExpenditure: 57000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459020010991/alna-20191231.xml#147133 Filing: 000156459020010991 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 35.65 million Exact value Exact value: -35648000 USD 2018-01-01 – 2018-12-31: -35648000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2018-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -35648000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35648000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459021012238/alna-20201231.xml#133102 Filing: 000156459021012238 The citation records this snapshot. The page link may show a newer release later.	−USD 31.84 million Exact value Exact value: -31839000 USD 2018-01-01 – 2018-12-31: -31839000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2018-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -31839000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31839000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459021012238/alna-20201231.xml#156452 Filing: 000156459021012238 The citation records this snapshot. The page link may show a newer release later.	USD 318,000 Exact value Exact value: 318000 USD 2018-01-01 – 2018-12-31: 318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2018-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 318000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 318000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459021012238/alna-20201231.xml#157082 Filing: 000156459021012238 The citation records this snapshot. The page link may show a newer release later.	−USD 32.16 million Calculation and evidence -31839000 − 318000 USD Exact free cash flow: -32157000 USD 2018-01-01 – 2018-12-31: -31839000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2018-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -32157000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31839000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459021012238/alna-20201231.xml#156452 Filing: 000156459021012238 Input fundies:CapitalExpenditure: 318000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000156459021012238/alna-20201231.xml#157082 Filing: 000156459021012238 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 47.34 million Exact value Exact value: -47339000 USD 2019-01-01 – 2019-12-31: -47339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2019-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -47339000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47339000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2643120 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 43.63 million Exact value Exact value: -43632000 USD 2019-01-01 – 2019-12-31: -43632000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2019-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -43632000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43632000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2380606 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	USD 122,000 Exact value Exact value: 122000 USD 2019-01-01 – 2019-12-31: 122000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2019-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 122000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 122000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2390770 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 43.75 million Calculation and evidence -43632000 − 122000 USD Exact free cash flow: -43754000 USD 2019-01-01 – 2019-12-31: -43632000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 122000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2019-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -43754000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43632000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2380606 Filing: 000095017022005192 Input fundies:CapitalExpenditure: 122000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2390770 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 32.85 million Exact value Exact value: -32845000 USD 2020-01-01 – 2020-12-31: -32845000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2020-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -32845000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32845000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#3514974 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 28.16 million Exact value Exact value: -28159000 USD 2020-01-01 – 2020-12-31: -28159000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2020-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -28159000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2378621 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	USD 650,000 Exact value Exact value: 650000 USD 2020-01-01 – 2020-12-31: 650000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2020-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 650000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 650000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2388797 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 28.81 million Calculation and evidence -28159000 − 650000 USD Exact free cash flow: -28809000 USD 2020-01-01 – 2020-12-31: -28159000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 650000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2020-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -28809000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2378621 Filing: 000095017022005192 Input fundies:CapitalExpenditure: 650000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2388797 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 48.66 million Exact value Exact value: -48663000 USD 2021-01-01 – 2021-12-31: -48663000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Net Income: -48663000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48663000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#3457769 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 45.68 million Exact value Exact value: -45678000 USD 2021-01-01 – 2021-12-31: -45678000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Operating Cash Flow: -45678000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45678000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2376636 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	USD 667,000 Exact value Exact value: 667000 USD 2021-01-01 – 2021-12-31: 667000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Capital Expenditure: 667000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 667000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2386824 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.	−USD 46.35 million Calculation and evidence -45678000 − 667000 USD Exact free cash flow: -46345000 USD 2021-01-01 – 2021-12-31: -45678000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 667000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLENA PHARMACEUTICALS, INC. · 2021-12-31 ALLENA PHARMACEUTICALS, INC. (edgar:1624658) Free cash flow: -46345000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T22:02:45Z Snapshot: d7c886ee9f83fb1232376483cffd6c35718fc2d8dc19e56a8caa9f1a883f52de Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624658?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45678000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2376636 Filing: 000095017022005192 Input fundies:CapitalExpenditure: 667000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624658/000095017022005192/alna-20211231.htm#2386824 Filing: 000095017022005192 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 1,143 latest values · 1,143 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001624658, 1624658, ALNA, edgar:1624658

Also known as ALLENA PHARMACEUTICALS, INC., Allena Pharmaceuticals, Inc.

ALLENA PHARMACEUTICALS, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation